118 related articles for article (PubMed ID: 7658075)
21. [Macrolide and linezolid susceptibility testing for Mycobacterium intracellulare isolates].
Duan H; Liang Q; Chu N; Huang H
Zhonghua Jie He He Hu Xi Za Zhi; 2014 Apr; 37(4):266-9. PubMed ID: 24969714
[TBL] [Abstract][Full Text] [Related]
22. Antimicrobial activity of picolinic acid against extracellular and intracellular Mycobacterium avium complex and its combined activity with clarithromycin, rifampicin and fluoroquinolones.
Cai S; Sato K; Shimizu T; Yamabe S; Hiraki M; Sano C; Tomioka H
J Antimicrob Chemother; 2006 Jan; 57(1):85-93. PubMed ID: 16303883
[TBL] [Abstract][Full Text] [Related]
23. Activity of KRM 1648 or rifabutin alone or in combination with clarithromycin against Mycobacterium avium complex in human alveolar macrophages.
Suzuki K; Tsuyuguchi K; Matsumoto H; Yamamoto T; Hashimoto T; Tanaka E; Amitani R; Kuze F
Int J Tuberc Lung Dis; 1997 Oct; 1(5):460-7. PubMed ID: 9441102
[TBL] [Abstract][Full Text] [Related]
24. In vitro activities of clarithromycin and azithromycin against clinical isolates of Mycobacterium avium-M. intracellulare.
Steele-Moore L; Stark K; Holloway WJ
Antimicrob Agents Chemother; 1999 Jun; 43(6):1530. PubMed ID: 10383373
[No Abstract] [Full Text] [Related]
25. Activity of rifabutin, clarithromycin, ethambutol, sparfloxacin and amikacin, alone and in combination, against Mycobacterium avium complex in human macrophages.
Pellegrin I; Maugein J; Lapeyre C; Barbeau P; Leng B; Pellegrin JL
J Antimicrob Chemother; 1996 Mar; 37(3):501-10. PubMed ID: 9182107
[TBL] [Abstract][Full Text] [Related]
26. Activities of amikacin, roxithromycin, and azithromycin alone or in combination with tumor necrosis factor against Mycobacterium avium complex.
Bermudez LE; Young LS
Antimicrob Agents Chemother; 1988 Aug; 32(8):1149-53. PubMed ID: 2847644
[TBL] [Abstract][Full Text] [Related]
27. Azithromycin and clarithromycin inhibit lipopolysaccharide-induced murine pulmonary neutrophilia mainly through effects on macrophage-derived granulocyte-macrophage colony-stimulating factor and interleukin-1beta.
Bosnar M; Bosnjak B; Cuzic S; Hrvacic B; Marjanovic N; Glojnaric I; Culic O; Parnham MJ; Erakovic Haber V
J Pharmacol Exp Ther; 2009 Oct; 331(1):104-13. PubMed ID: 19633061
[TBL] [Abstract][Full Text] [Related]
28. Activities of clarithromycin, sulfisoxazole, and rifabutin against Mycobacterium avium complex multiplication within human macrophages.
Perronne C; Gikas A; Truffot-Pernot C; Grosset J; Pocidalo JJ; Vilde JL
Antimicrob Agents Chemother; 1990 Aug; 34(8):1508-11. PubMed ID: 2171421
[TBL] [Abstract][Full Text] [Related]
29. Recombinant granulocyte-macrophage colony-stimulating factor (GM-CSF) or tumour necrosis factor-alpha (TNF-alpha) activate human alveolar macrophages to inhibit growth of Mycobacterium avium complex.
Suzuki K; Lee WJ; Hashimoto T; Tanaka E; Murayama T; Amitani R; Yamamoto K; Kuze F
Clin Exp Immunol; 1994 Oct; 98(1):169-73. PubMed ID: 7923877
[TBL] [Abstract][Full Text] [Related]
30. Mycobacterium avium strains resistant to clarithromycin and azithromycin.
Heifets L; Mor N; Vanderkolk J
Antimicrob Agents Chemother; 1993 Nov; 37(11):2364-70. PubMed ID: 8031351
[TBL] [Abstract][Full Text] [Related]
31. Activity of moxifloxacin by itself and in combination with ethambutol, rifabutin, and azithromycin in vitro and in vivo against Mycobacterium avium.
Bermudez LE; Inderlied CB; Kolonoski P; Petrofsky M; Aralar P; Wu M; Young LS
Antimicrob Agents Chemother; 2001 Jan; 45(1):217-22. PubMed ID: 11120969
[TBL] [Abstract][Full Text] [Related]
32. Prevention strategies for Mycobacterium avium-intracellulare complex (MAC) infection. A review of recent studies in patients with AIDS.
Cohn DL
Drugs; 1997; 54 Suppl 2():8-15; discussion 28-9. PubMed ID: 9358195
[TBL] [Abstract][Full Text] [Related]
33. Killing of Mycobacterium avium by neutrophils and monocytes from AIDS patients treated with recombinant granulocyte-macrophage colony-stimulating factor.
Cinti S; Coffey M; Sullivan A; Kazanjian P
J Infect Dis; 1999 Jul; 180(1):229-33. PubMed ID: 10353887
[TBL] [Abstract][Full Text] [Related]
34. Presence of macrolide resistance in respiratory flora of HIV-Infected patients receiving either clarithromycin or azithromycin for Mycobacterium avium complex prophylaxis.
Aberg JA; Wong MK; Flamm R; Notario GF; Jacobson MA
HIV Clin Trials; 2001; 2(6):453-9. PubMed ID: 11742432
[TBL] [Abstract][Full Text] [Related]
35. Intramacrophage passage of Mycobacterium tuberculosis and M. avium complex alters the drug susceptibilities of the organisms as determined by intracellular susceptibility testing using macrophages and type II alveolar epithelial cells.
Tomioka H; Sato K; Sano C; Sano K; Shimizu T
Antimicrob Agents Chemother; 2002 Feb; 46(2):519-21. PubMed ID: 11796367
[TBL] [Abstract][Full Text] [Related]
36. Induction of IL-1 beta, IL-6, TNF-alpha, GM-CSF and G-CSF in human macrophages by smooth transparent and smooth opaque colonial variants of Mycobacterium avium.
Fattorini L; Xiao Y; Li B; Santoro C; Ippoliti F; Orefici G
J Med Microbiol; 1994 Feb; 40(2):129-33. PubMed ID: 7508978
[TBL] [Abstract][Full Text] [Related]
37. Growth inhibition of Mycobacterium avium complex in human alveolar macrophages by the combination of recombinant macrophage colony-stimulating factor and interferon-gamma.
Rose RM; Fuglestad JM; Remington L
Am J Respir Cell Mol Biol; 1991 Mar; 4(3):248-54. PubMed ID: 1900425
[TBL] [Abstract][Full Text] [Related]
38. A subinhibitory concentration of clarithromycin inhibits Mycobacterium avium biofilm formation.
Carter G; Young LS; Bermudez LE
Antimicrob Agents Chemother; 2004 Dec; 48(12):4907-10. PubMed ID: 15561879
[TBL] [Abstract][Full Text] [Related]
39. Bidirectional effects of cytokines on the growth of Mycobacterium avium within human monocytes.
Shiratsuchi H; Johnson JL; Ellner JJ
J Immunol; 1991 May; 146(9):3165-70. PubMed ID: 1901893
[TBL] [Abstract][Full Text] [Related]
40. Killing by antimycobacterial agents of AIDS-derived strains of Mycobacterium avium complex inside cells of the mouse macrophage cell line J774.
Yajko DM; Nassos PS; Sanders CA; Hadley WK
Am Rev Respir Dis; 1989 Nov; 140(5):1198-203. PubMed ID: 2817581
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
